Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiviral therapy in HBV-related HCC with low viral load
NCT01894269Phase 4Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamivudine, entecavir in hepatocellular carcinoma (HCC), hepatitis B (HBV), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
lamivudineentecavir
03
Conditions
hepatocellular carcinoma (HCC)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01894269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01894269.